| [Overexpression of lncRNA FEZF1-AS1 promotes progression of non-small cell lung cancer via the miR-130a-5p/CCND1 axis]. | [Overexpression of lncRNA FEZF1-AS1 promotes progression of non-small cell lung cancer via the miR-130a-5p/CCND1 axis].
Li F, Xiang J, Liu J, Wang X, Jiang H., Free PMC Article | 06/21/2024 |
| Up-regulation of BOK-AS1, FAM215A and FEZF1-AS1 lncRNAs and their potency as moderate diagnostic biomarkers in gastric cancer. | Up-regulation of BOK-AS1, FAM215A and FEZF1-AS1 lncRNAs and their potency as moderate diagnostic biomarkers in gastric cancer.
Moazzen H, Rajabi A, Safaralizadeh R. | 08/19/2023 |
| Long non-coding RNA FEZF1-AS1 promotes rectal cancer progression by competitively binding miR-632 with FAM83A. | Long non-coding RNA FEZF1-AS1 promotes rectal cancer progression by competitively binding miR-632 with FAM83A.
Xie R, Liu C, Liu L, Lu X, Tang G., Free PMC Article | 05/28/2022 |
| Up-Regulated LncRNA FEZF1-AS1 Promotes the Progression of Cervical Carcinoma Cells via MiR-367-3p/SLC12A5 Signal Axis. | Up-Regulated LncRNA FEZF1-AS1 Promotes the Progression of Cervical Carcinoma Cells via MiR-367-3p/SLC12A5 Signal Axis.
Yang X, Qu Y, Zhang J. | 03/19/2022 |
| LncRNA FEZF1-AS1 aggravates cell proliferation and migration in glioblastoma. | LncRNA FEZF1-AS1 aggravates cell proliferation and migration in glioblastoma.
Zhou C, Jiang X, Liang A, Zhu R, Yang Y, Zhong L, Wan D. | 03/5/2022 |
| Upregulated long noncoding RNAs LINC02163 and FEZF1-AS1 exert oncogenic roles in colorectal cancer. | Upregulated long noncoding RNAs LINC02163 and FEZF1-AS1 exert oncogenic roles in colorectal cancer.
Tian Y, Zhou J, Zou Y, Luo B, Liu Q, Cao X. | 09/25/2021 |
| Long noncoding RNA FEZF1AS1 facilitates nonsmall cell lung cancer progression via the ITGA11/miR516b5p axis. | Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis.
Song H, Li H, Ding X, Li M, Shen H, Li Y, Zhang X, Xing L., Free PMC Article | 08/7/2021 |
| Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/beta-catenin axis. | Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis.
Yao J, Yang Z, Yang J, Wang ZG, Zhang ZY., Free PMC Article | 07/24/2021 |
| LncRNA FEZF1-AS1 accelerates the migration and invasion of laryngeal squamous cell carcinoma cells through miR-4497 targeting GBX2. | LncRNA FEZF1-AS1 accelerates the migration and invasion of laryngeal squamous cell carcinoma cells through miR-4497 targeting GBX2.
Chen X, Cheng P, Hu C. | 05/1/2021 |
| lncRNA FEZF1AS1 promotes migration, invasion and epithelialmesenchymal transition of retinoblastoma cells by targeting miR12363p. | lncRNA FEZF1‑AS1 promotes migration, invasion and epithelial‑mesenchymal transition of retinoblastoma cells by targeting miR‑1236‑3p.
Zhang G, Yang W, Li D, Li X, Huang J, Huang R, Luo J., Free PMC Article | 05/1/2021 |
| Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis. | Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
Sun Z, Gao S, Xuan L, Liu X., Free PMC Article | 05/1/2021 |
| LncRNA FEZF1-AS1 promotes non-small lung cancer cell migration and invasion through the up-regulation of NOTCH1 by serving as a sponge of miR-34a. | LncRNA FEZF1-AS1 promotes non-small lung cancer cell migration and invasion through the up-regulation of NOTCH1 by serving as a sponge of miR-34a.
Huang S, Li C, Huang J, Luo P, Mo D, Wang H., Free PMC Article | 02/2/2021 |
| Highly expressed long non-coding RNA FEZF1-AS1 promotes cells proliferation and metastasis through Notch signaling in prostate cancer. | Highly expressed long non-coding RNA FEZF1-AS1 promotes cells proliferation and metastasis through Notch signaling in prostate cancer.
Zhu LF, Song LD, Xu Q, Zhan JF. | 09/19/2020 |
| FEZF1-AS1: a novel vital oncogenic lncRNA in multiple human malignancies. | FEZF1-AS1: a novel vital oncogenic lncRNA in multiple human malignancies.
Shi C, Sun L, Song Y., Free PMC Article | 08/13/2020 |
| Loss-of-function study indicated silencing FEZF1-AS1 expression inhibited retinoblastoma cell proliferation, invasion and migration. In conclusion, FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma. | FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma.
Quan LJ, Wang WJ., Free PMC Article | 07/4/2020 |
| role of FEZF1-AS1 in carcinogenesis and progression suggests that it may be a potential diagnostic biomarker or a novel therapeutic target for cancers | Long noncoding RNA FEZF1-AS1 in human cancers.
Zhou Y, Xu S, Xia H, Gao Z, Huang R, Tang E, Jiang X. | 02/15/2020 |
| these data provide mechanistic insights into the regulation of FEZF1-AS1 on both STAT3 signaling and glycolysis by binding PKM2 and increasing its stability. | LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.
Bian Z, Zhang J, Li M, Feng Y, Wang X, Zhang J, Yao S, Jin G, Du J, Han W, Yin Y, Huang S, Fei B, Zou J, Huang Z. | 12/14/2019 |
| our study validate the important role of FEZF1-AS1/miR-30a/Nanog in breast cancer stemness and tumorigenesis, providing a novel insight and treatment strategy for breast cancer. | Long non-coding RNA FEZF1-AS1 promotes breast cancer stemness and tumorigenesis via targeting miR-30a/Nanog axis.
Zhang Z, Sun L, Zhang Y, Lu G, Li Y, Wei Z. | 09/28/2019 |
| Study shows that increased lncRNA FEZF1- AS1 expression is significantly associated with unfavorable clinical outcomes in patients with solid tumors. As a vital node in the gene expression pathway, lncRNA FEZF1-AS1 is regulated by upstream molecules and regulating the occurrence and progression of cancer cells in multiple ways. [meta-analysis] | Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
Zhang Y, Yang QX, Peng TT, Wang LJ, Xiao GL, Tang SB., Free PMC Article | 06/29/2019 |
| the results of the present study demonstrated that FEZF1-AS1 promoted the proliferation, migration and invasion of HCC cells by regulating miR-4443 expression levels. The present results highlight the importance of the FEZF1-AS1/miR-4443 axis during HCC development and progression. | lncRNA FEZF1‑AS1 contributes to cell proliferation, migration and invasion by sponging miR‑4443 in hepatocellular carcinoma.
Gong J, Wang J, Liu T, Hu J, Zheng J., Free PMC Article | 02/2/2019 |
| FEZF1-AS1 acts as an oncogenic lncRNA in human hepatocellular carcinoma by promoting JAK2/STAT3 signaling-mediated epithelial mesenchymal transformation. | Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
Wang YD, Sun XJ, Yin JJ, Yin M, Wang W, Nie ZQ, Xu J. | 12/22/2018 |
| FEZF1-AS1 promoted multiple myeloma cells proliferation through regulating miR-610/Akt3 axis. | Long non-coding RNA FEZF1-AS1 promotes cell growth in multiple myeloma via miR-610/Akt3 axis.
Li QY, Chen L, Hu N, Zhao H. | 10/13/2018 |
| These results suggest that lncRNA FEZF-AS1 relate to the progression of lung cancer patients | Upregulation of LncRNA FEZF-AS1 is associated with advanced clinical stages and family history of cancer in patients with NSCLC.
Gong W, Cao Y, Wang Y, Yang L, Su W, Qiu F, Datta S, Rao B, Xian J, Lin M, Feng Y, Zhang X, Zhou Y, Gao X, Lu J. | 09/29/2018 |
| Results provide evidence that FEZF1-AS1 is overexpressed in gastric cancer tissues; its overexpression may predict poor prognosis. FEZF1-AS1 promoted gastric cancer cell proliferation and tumorigenesis by affecting cell cycle progression partly through suppressing P21 expression. | LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation.
Liu YW, Xia R, Lu K, Xie M, Yang F, Sun M, De W, Wang C, Ji G., Free PMC Article | 02/10/2018 |
| Findings indicate that the dysregulation of FEZF1-AS1 participates in colorectal tumorigenesis and progression, which might be achieved, at least in part, through FEZF1 induction. | Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma.
Chen N, Guo D, Xu Q, Yang M, Wang D, Peng M, Ding Y, Wang S, Zhou J., Free PMC Article | 12/2/2017 |